Basic Information
AQILION is a biotech company that focuses on developing innovative therapies to treat diseases caused by chronic inflammation and dysfunctional immune responses, such as autoimmune diseases. The company is primarily active in the early stages of drug discovery, from concept to early clinical development. AQILION combines its experience in large pharmaceutical companies with the drive and entrepreneurial spirit of a small growth company.